|
|
Volumn 14, Issue 2, 2011, Pages 77-78
|
|
The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADVERSE OUTCOME;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
CONFERENCE PAPER;
CONTINUING EDUCATION;
DRUG COST;
DRUG INDUSTRY;
DRUG MARKETING;
PRIORITY JOURNAL;
PRODUCT DEVELOPMENT;
PROSPECTIVE PRICING;
REIMBURSEMENT;
TREATMENT INDICATION;
ANTI-BACTERIAL AGENTS;
BACTERIA;
BACTERIAL INFECTIONS;
COMMERCE;
DRUG DISCOVERY;
DRUG INDUSTRY;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
INVESTMENTS;
PANDEMICS;
RESEARCH SUPPORT AS TOPIC;
|
|
EID: 79955770863
PISSN: 13687646
EISSN: None
Source Type: Journal
DOI: 10.1016/j.drup.2011.01.005 Document Type: Conference Paper |
|
Times cited : (11)
|
|
References (0)
|
